TGA approves more flexible storage conditions for Pfizer-Bio

TGA approves more flexible storage conditions for Pfizer-BioNTech COVID-19 vaccine


TGA
On Monday 24 May 2021, the TGA approved an application from Pfizer Australia Pty Ltd to change its current storage conditions for its COVID-19 vaccine, COMIRNATY
TM. The TGA received the application on Thursday May 20, 2021.
This change extends the approved storage period of the unopened thawed vial at 2-8°C (i.e. in a normal refrigerator after taking out of deep-freeze conditions) at the point of use from five days up to one month (31 days). The changed storage requirements will enable much greater flexibility in the distribution of the vaccine and have a significant impact on the roll out of the vaccine across Australia.

Related Keywords

Australia , , Pfizer , Pfizer Australia Pty Ltd , Thursday May , Product Information , Therapeutic Goods Administration , Ga , Healthcare , Covid 19 , Vaccine , Impact , Study , ஆஸ்திரேலியா , ஃபைசர் , ஃபைசர் ஆஸ்திரேலியா ப்டி லிமிடெட் , வியாழன் இருக்கலாம் , ப்ராடக்ட் தகவல் , க , விட் ,

© 2025 Vimarsana